Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ATNF
- Price
- 16.80
- Stock movement down
- -0.42 (-8.03%)
- Company name
- 180 Life Sciences Corp
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 736.08M
- Ent value
- 742.63M
- Price/Sales
- 2216.72
- Price/Book
- 197.14
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- 154.50%
- 3 year return (CAGR)
- -77.28%
- 5 year return (CAGR)
- -74.17%
- 10 year return (CAGR)
- -
Last updated: 2025-09-12
DIVIDENDS
ATNF does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2216.72 |
| Price to Book | 197.14 |
| EV to Sales | 2236.42 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 153.03M |
| EPS (TTM) | -3.18 |
| FCF per share (TTM) | -2.74 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 332.06K |
| Gross profit (TTM) | 95.81K |
| Operating income (TTM) | -6.37M |
| Net income (TTM) | -3.12M |
| EPS (TTM) | -3.18 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 28.85% |
| Operating margin (TTM) | -1918.57% |
| Profit margin (TTM) | -940.13% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.22M |
| Net receivables | 10.78K |
| Total current assets | 3.09M |
| Goodwill | 0.00 |
| Intangible assets | 7.62M |
| Property, plant and equipment | 0.00 |
| Total assets | 10.71M |
| Accounts payable | 2.20M |
| Short/Current long term debt | 1.41M |
| Total current liabilities | 5.33M |
| Total liabilities | 5.33M |
| Shareholder's equity | 5.38M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -2.69M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -2.69M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -83.61% |
| Return on Assets | -29.82% |
| Return on Invested Capital | -74.21% |
| Cash Return on Invested Capital | -63.94% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 5.25 |
| Daily high | 5.44 |
| Daily low | 4.53 |
| Daily Volume | 8.88M |
| All-time high | 4552.40 |
| 1y analyst estimate | 80.00 |
| Beta | 0.41 |
| EPS (TTM) | -3.18 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ATNF | S&P500 | |
| Current price drop from All-time high | -99.63% | -1.30% |
| Highest price drop | -99.98% | -19.00% |
| Date of highest drop | 10 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -70.10% | -2.49% |
| Avg time to new high | 26 days | 6 days |
| Max time to new high | 1097 days | 89 days |
COMPANY DETAILS
Marketcap
736.08M
Marketcap category
Small-cap
Description
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. The company product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; and Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain. 180 Life Sciences Corp. is headquartered in Palo Alto, California.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner